Healthcare · Medical Devices
Neuralink
Series E
Implied valuation
$00 B
Live tracking
IPO Odds00 %modeled estimate
Probability modeled from funding stage, momentum & liquidity signals.
Valuation Trajectory
1.3K×
since foundingJun 2016Jun 2026
Funding-round staircase from founding · log scale. Modeled round ladder anchored to the current valuation — illustrative, not a published figure.
IPO Model Drivers
Why the odds read this way
Financing stage
Series EScale & liquidity pull
Private-market valuationValuation momentum
-30.2% trailingFactor weights are illustrative decompositions of the modeled IPO probability, not guarantees.
Down-Round Risk
Valuation downside pressure
Moderate
Mixed signals — limited valuation history with 38% modeled IPO odds keep down-round risk in the middle band.
Asset brief
Neuralink is a Healthcare · Medical Devices company last marked at $9.65B. Stage: Series E. No verified market-moving events in the last 30 days.
Capital Timeline
Funding & liquidity milestones
Series E
$9.65B
Backed by
No disclosed investors yet.
Comparables
Healthcare
Signals
No recent signals for Neuralink.